192 related articles for article (PubMed ID: 26715200)
1. C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads.
Syha R; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
Cancer Imaging; 2015 Dec; 15():22. PubMed ID: 26715200
[TBL] [Abstract][Full Text] [Related]
2. Parenchymal Blood Volume Assessed by C-Arm-Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma.
Syha R; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
Invest Radiol; 2016 Feb; 51(2):121-6. PubMed ID: 26488373
[TBL] [Abstract][Full Text] [Related]
3. Image quality of arterial phase and parenchymal blood volume (PBV) maps derived from C-arm computed tomography in the evaluation of transarterial chemoembolization.
Zitzelsberger T; Syha R; Grözinger G; Partovi S; Nikolaou K; Grosse U
Cancer Imaging; 2018 May; 18(1):16. PubMed ID: 29720249
[TBL] [Abstract][Full Text] [Related]
4. Intraprocedural blood volume measurement using C-arm CT as a predictor for treatment response of malignant liver tumours undergoing repetitive transarterial chemoembolization (TACE).
Vogl TJ; Schaefer P; Lehnert T; Nour-Eldin NE; Ackermann H; Mbalisike E; Hammerstingl R; Eichler K; Zangos S; Naguib NN
Eur Radiol; 2016 Mar; 26(3):755-63. PubMed ID: 26123407
[TBL] [Abstract][Full Text] [Related]
5. Intraprocedural cone-beam CT with parenchymal blood volume assessment for transarterial chemoembolization guidance: Impact on the effectiveness of the individual TACE sessions compared to DSA guidance alone.
Peisen F; Maurer M; Grosse U; Nikolaou K; Syha R; Artzner C; Bitzer M; Horger M; Grözinger G
Eur J Radiol; 2021 Jul; 140():109768. PubMed ID: 33991970
[TBL] [Abstract][Full Text] [Related]
6. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
[TBL] [Abstract][Full Text] [Related]
7. The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
Kim KA; Choi SY; Kim MU; Baek SY; Park SH; Yoo K; Kim TH; Kim HY
J Vasc Interv Radiol; 2019 Mar; 30(3):358-369. PubMed ID: 30819478
[TBL] [Abstract][Full Text] [Related]
8. C-arm computed tomography and volume perfusion computed tomography (VPCT)-based assessment of blood volume changes in hepatocellular carcinoma in prediction of midterm tumor response to transarterial chemoembolization: a single center retrospective trial.
Syha R; Gatidis S; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
Cancer Imaging; 2016 Sep; 16(1):30. PubMed ID: 27654658
[TBL] [Abstract][Full Text] [Related]
9. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: Impact of Embolic Density and Residual Tumor Perfusion on Tumor Recurrence and Survival.
Ruff C; Artzner C; Syha R; Grosse U; Hoffmann R; Bitzer M; Partovi S; Horger M; Nikolaou K; Grözinger G
Cardiovasc Intervent Radiol; 2021 Sep; 44(9):1403-1413. PubMed ID: 34021375
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: initial tumour response after short-term and long-interval chemoembolization with drug-eluting beads using modified RECIST.
Syha R; Ketelsen D; Heller S; Schmehl J; Mangold S; Heuschmid M; Springer F; Claussen CD; Brechtel K
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1325-32. PubMed ID: 22872074
[TBL] [Abstract][Full Text] [Related]
11. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
Chen G; Ma DQ; He W; Zhang BF; Zhao LQ
World J Gastroenterol; 2008 Oct; 14(37):5738-43. PubMed ID: 18837093
[TBL] [Abstract][Full Text] [Related]
13. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
Kaufmann S; Schulze M; Spira D; Horger M
Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848
[TBL] [Abstract][Full Text] [Related]
14. Computed tomographic perfusion with 160-mm coverage: comparative analysis of hepatocellular carcinoma treated by two transarterial chemoembolization courses relative to magnetic resonance imaging findings.
Bayle M; Clerc-Urmès I; Ayav A; Bronowicki JP; Petit I; Orry X; Laurent V
Abdom Radiol (NY); 2019 Jan; 44(1):85-94. PubMed ID: 30054686
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
[TBL] [Abstract][Full Text] [Related]
16. Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.
Najmi Varzaneh F; Pandey A; Aliyari Ghasabeh M; Shao N; Khoshpouri P; Pandey P; Zarghampour M; Fouladi D; Liddell R; Anders RA; Kamel IR
Eur Radiol; 2018 Jul; 28(7):3032-3040. PubMed ID: 29383518
[TBL] [Abstract][Full Text] [Related]
17. Accurate and rapid identification of feeding arteries with multidetector-row angiography-assisted computed tomography for transarterial chemoembolization for hepatocellular carcinoma.
Takada K; Toyoda H; Tada T; Ito T; Hasegawa R; Gotoh T; Ichikawa H; Sone Y; Kumada T
J Gastroenterol; 2015 Dec; 50(12):1190-6. PubMed ID: 25791518
[TBL] [Abstract][Full Text] [Related]
18. C-arm cone-beam CT parenchymal blood volume imaging for transarterial chemoembolization of hepatocellular carcinoma: implications for treatment planning and response.
O'Donohoe RL; Kavanagh RG; Cahalane AM; Houlihan DD; McCann JW; Ryan ER
Eur Radiol Exp; 2019 May; 3(1):21. PubMed ID: 31144237
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of assessing pulmonary blood volume using C-arm CT during transpulmonary chemoperfusion and chemoembolization in primary and secondary lung tumours.
Vogl TJ; Nour-Eldin NE; Naguib NN; Lehnert T; Ackermann H; Hammerstingl R; Hezel M
Br J Radiol; 2016 Jun; 89(1062):20150244. PubMed ID: 27046514
[TBL] [Abstract][Full Text] [Related]
20. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
